【レポートの概要（一部）】
1. Report Overview
1.1 Cell-Based Assays Overview
1.2 Cell-Based Assays Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Questions Answered by this Report
1.6 Who is this Report for?
1.7 Research Methods and Analysis
1.8 Frequently Asked Questions
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Cell-Based Assays and Applications
2.1 Cost of New Drug Discovery and Development Reaches $2.6bn – Companies Constantly Looking for Increased Efficiencies
2.2 Drug Discovery Approaches – Target-Based and Phenotype-Based Discovery
2.3 Drug Screening Assays
2.4 Animal Models Present In Vivo Conditions: But Do Results Translate to Humans?
2.5 Biochemical Assays and their Advantages over Animal Models
2.5.1 Applications of Biochemical Assays
2.5.2 Lead Identification and Toxicity Testing
2.6 Cell-Based Assays and their Advantages
2.7 2D vs 3D Cell-Based Assays
2.8 Advanced Cell-Based Assays
2.9 The Different Assay Detection Methods and Technologies
2.10 Cells used in Cell-Based Assays
2.10.1 Immortalised Cell Lines – Convenient but not Truly Representative of Normal Human Cell Lines
2.10.2 Primary Cells: Closer to the In Vivo Environment
2.10.3 Stem Cells: Potential to Overcome Limitations of Primary cells and Immortalised Cell Lines
2.11 Uses for Cell-Based Assays in Drug Discovery and Development
2.11.1 Target Validation
2.11.2 Primary Screening
2.11.3 Secondary Screening
2.11.4 ADME Screening
2.11.5 High Throughput Screening: Greatly Increases Efficiency
3. World Cell-Based Assays Market 2016-2026
3.1 Global Cell-Based Assays Market Forecast 2016-2026
3.2 Drivers for the Cell-Based Assays Market
3.3 Restraints for the Cell-Based Assays Market
3.4 Cell-Based Assays: Market Segments – Products and Services
3.5 Cell-Based Assays, Market Segments: Products Forecast 2016-2026
3.5.1 The Four Main Categories of Cell-Based Assay Products
3.5.1.1 Equipment Needed to Conduct Cell-Based Assays
3.5.1.2 Disposables Necessary to Perform Cell-Based Assays
3.5.1.3 Consumables Forming the Basis of Cell-Based Assays
3.5.1.4 Biobanks
3.6 Cell-Based Assays Market Segments: Services
3.6.1 Cell-Based Assays Market Segments: Services Forecast 2016-2026
3.7 Cell-Based Assays Market: Applications Forecasts 2016-2026
3.7.1 Drug Discovery Segment
3.7.2 ADME (Absorption, Distribution, Metabolism, Excretion) Segment
3.7.3 Basic Research Segment
4. Leading National Markets for Cell-Based Assays, 2016-2026
4.1 Regional Breakdown of the Global Cell-Based Assays Market, 2016-2026
4.2 Global Cell-Based Assays market: Regional Forecast 2016-2026
4.3 The US Cell-Based Assays Revenue Forecast 2016-2026
4.4 European Union (EU) Cell-Based Assays Market 2016-2026
4.4.1 IMI’s Pan-European Drug Discovery Platform holds Much Promise
4.4.2 EU National Market Share Breakdown, 2015, 2020 and 2026
4.4.3 EU Market: Main National Forecasts, 2016-2026
4.4.4 German Cell-Based Assay Revenue Forecast, 2016-2026
4.4.5 French Cell-Based Assays Revenue Forecast, 2016-2026
4.4.6 UK Cell-Based Assays Revenue Forecast, 2016-2026
4.4.7 Spanish Cell-Based Assays Revenue Forecast, 2016-2026
4.4.8 Italian Cell-Based Assays Revenue Forecast, 2016-2026
4.5 Japanese Cell-Based Assays Revenue Forecast, 2016-2026
4.6 BRIC Nations (Brazil, Russia, India and China) Cell-Based Assays Market
4.6.1 BRIC Countries National Breakdown, 2015, 2020 and 2026
4.6.2 BRIC Countries National Forecasts, 2016-2026
4.6.3 Chinese Cell-Based assay Revenue Forecast, 2016-2026
4.6.4 Indian Cell-Based Assays Revenue Forecast, 2016-2026
4.6.5 Russian Cell-Based Assays Revenue Forecast, 2016-2026
4.6.6 Brazilian Cell-Based Assays Revenue Forecast, 2016-2026
5. Leading Companies in the Cell-Based Assays Market: Product Suppliers, 2016
5.1 Thermo Fisher Scientific
5.1.1 ThermoFisher Scientific Financial Figures
5.1.2 Recent Developments at ThermoFisher Scientific
5.1.2.1 ThermoFisher Acquires Affymetrix
5.1.3 Cell-Based Assay Technologies under ThermoFisher’s Life Science Solutions Segment
5.2 DiscoveRx
5.2.1 DiscoveRx Assay Platforms and Technology
5.3 PerkinElmer
5.3.1 AlphaScreen Technology
5.3.2 DELFIA TRF Assays
5.3.3 Label-Free Cellular Assay Detection/Opera System
5.4 BD (Becton, Dickinson and Company)
5.4.1 Cell-Based Assays Through BD Life Sciences
5.5 InSphero
5.5.1 GravityPLUS – Leading Solution for 3D Cell-Based Assays
5.6 QGel
5.6.1 QGel Products and Services
5.7 Biocroi
5.7.1 Happy Cell ASM and its 3D Cell Culture
5.8 GE Healthcare
5.8.1 Cell-Based Assays Through GE Healthcare Life Sciences
5.9 Molecular Devices
5.9.1 Cell-Based Assay Products Include SpectraMax Microplate Readers and FLIPR Tetra System
5.10 Promega
5.10.1 Assays Range from Cell Viability Assays to Mitochondrial Function Assays
5.11 BioVision
5.11.1 Cell-Based Assays Include the EZCell Platform and a Cholesterol Detection Kit
6. Leading Companies in the Cell-Based Assays Market: CROs and Service Providers, 2016
6.1 Porsolt: Acquires Fluofarma
6.1.1 Fluofarma
6.1.2 Fluofarma has Over 100 Cell-Based Assays
6.2 CYTOO
6.2.1 Cell Micropatterning to Eliminate Trade-off Between Quantity and Quality?
6.2.2 Cell-Based Assays for Muscular Atrophy/Hypertrophy and Anti-Cancer Drug Profiling
6.3 Cell Assay Innovations (CAI)
6.3.1 ClariCELL Technology
6.4 ProQinase
6.4.1 ProQinase Cell-Based Assay Services, 2016
6.5 Charles River Laboratories
6.5.1 PhenoFocus – Portfolio of over 100 Primary Cell-Based Assays
6.6 BioAgilytix
6.7 SGS
6.7.1 Offers a Range of Services, Including 3D Cell-Based Assays
6.8 Pharmaceutical Product Development
6.9 Marin Biologic Laboratories
7. Cell-Based Assays Technology, Trends and Future Outlook
7.1 Stem Cells: Vast Potential
7.1.1 The Benefits of Using Stem Cells in Cell-Based Assays
7.1.2 iPSCs: An Uncontroversial and Abundant Source
7.1.3 Companies Providing Stem Cell-Based Assays
7.2 Toxicity Testing: Important Field for Cell-Based Assays
7.3 3D Systems: The Advantages of Next Generation of Cell Systems
7.3.1 Complexity of 3D Systems is a Challenge but More are Reaching the Market
7.3.2 Organoids – The Future of Drug Development?
7.3.2.1 Hurdles to the Future Organoid Market
7.3.2.2 Organoids Now and in the Future
7.3.3 Bio-Printing for Drug Development: Using 3D Printing Technology
7.4 Increasing Outsourcing of Cell-Based Assays
7.5 Label-Free Technology
7.6 GPCRs: A Common Drug and Drug Discovery Target
7.6.1 GPCRs in Cell-Based Assays
7.6.2 Allosteric GPCRs
7.7 Increasing Miniaturisation and Automation
7.7.1 Advantages of Miniaturisation
7.7.2 Advantages of Automation
7.8 Microfluids are Set to be a Trend
7.8.1 The Potential Challenges to Microfluids
7.9 Multiplexing: Improves Efficiency of cell-Based Assays
7.9.1 Advantages will Drive Growth
7.10 High Content Screening: A Well Established Tool
7.10.1 The Future for HCS: Will Continue to Expand, Still Room for Innovation
7.11 Cell-Based Assays for the Development of Biologics
8. Qualitative Analysis of the Cell-Based Assays Market, 2016
8.1 SWOT Analysis of the Cell-Based Assays Market
8.1.1 Strengths Within the Cell-Based Assay Market
8.1.2 Weaknesses Within the Cell-Based Assays Market
8.1.3 Opportunities for the Cell-Based Assays Market
8.1.4 Threats to the Cell-Based Assays Market
8.2 STEP Analysis of the Cell-Based Assays Market
8.2.1 Social Factors
8.2.2 Technological Factors
8.2.3 Economic Factors
8.2.4 Political Factors
9. Research Interviews
9.1 Interview with Dr Colin Sanctuary, CEO of QGel
9.1.1 On the Definition of Cell-Based Assays
9.1.2 On QGel Company Background and QGel Offerings
9.1.3 On the Cell-Based Assay Market Now and in the Future
9.1.4 On the Challenges to Cell-Based Assays and the Cell-Based Assay Market
9.1.5 On Considerations to Take when Purchasing Cell-Based Assays
10. Conclusions from the Research and Analysis
10.1 Growth Has Been Driven by Advantages of Cell-Based Assays
10.2 Current Status of the Market and its Growth Drivers
10.3 The Most Dominant National Markets and Emerging Countries
10.4 Future Trends and Technology
【レポート販売概要】
■ タイトル：セルベースアッセイの世界市場2016-2026■ 英文：Cell-Based Assays World Industry and Market Prospects 2016-2026
■ 発行日：2016年5月
■ 調査会社：visiongain
■ 商品コード：VGAIN60621
■ 調査対象地域：グローバル
- 世界のヘパリン検査市場The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Heparin testing specifically, will become more standardized, offering opp …
- セラミックス基複合材料の世界市場：酸化物/酸化物、SiC/SiC、炭素/炭素セラミックス基複合材料The report on ceramic matrix composites captures its global market size by volume and value. This market is growing at a rapid pace in Asia-Pacific and North America. The demand for ceramic matrix composites is driven by the following factors: • The growing demand for light-weight components in aircrafts for improving aircraft efficiency is driving the market for ceramic matrix composites. It is c …
- 凝集剤の世界市場2017-2021About Flocculants Flocculation is a process that assists in particle cluster formation, thus effectually separating harmful particles from waste water. It is an essential phenomenon in industrial wastewater treatment. Water usually contains organic matter such as bacteria, particles of decayed plants, and plankton, which makes it contaminated. In the following plant flow diagram, a typical wastewa …
- Richard Wolf GmbH：市場シェア分析Richard Wolf GmbH Market Share Analysis Summary GlobalData’s new report, “Richard Wolf GmbH Market Share Analysis” provides in-depth information on Richard Wolf GmbH’s market position in the different medical equipment markets it operates in. The report provides Richard Wolf GmbH market share information in two key market categories – Rigid Endoscopes and Flexible Endoscopes. The report also provi …
- 加入者データ管理市場（The Subscriber Data Management (SDM) Market: 2012 – 2016）Subscriber data is a principal asset held by network carriers. Subscriber Data Management (SDM) allows carriers to consolidate and manage their cross domain subscriber data encompassing access preferences, authentication, services, identities, location, and presence into unified data repositories. Besides enabling considerable OPEX reductions and allowing carriers to deliver more personalised serv …
- アンチエイジング製品および治療の世界市場2015-2022According to Stratistics MRC, the Global Anti-Aging Products and Therapies market is accounted for $127.9 billion in 2015 and is expected to reach $237.8 billion by 2022 growing at a CAGR of 9.2% from 2015 to 2022. Factors such as increasing demand for anti-aging hair care products, rise in urbanization and per capita income, advancement in cosmetic technologies, Laser/Energy-Based Cosmetic Treatm …
- 電子保安の世界市場：映像監視、アクセス制御、侵入検知、車両セキュリティAbout Physical Security Physical security refers to security measures that help to monitor and control access of an entity to premises, or equipment, or resources. These measures protect individuals and property from theft or attacks. Physical security involves the use of multiple layers of security products, such as surveillance systems, locks, and access control systems. It is mainly divided int …
- リン酸鉄リチウム（LiFePO4）の材料と電池の世界市場分析：原材料別（グラファイト、リン酸鉄リチウム、フッ化リチウム）、用途別、地域別、セグメント予測、2014-2025The global lithium iron phosphate material and battery market is expected to reach USD 25.47 billion by 2025, according to a new report by Grand View Research, Inc. Growing demand for these batteries from the electric & hybrid electric vehicles and consumer electronics segments is expected to be the biggest driver of the market over the next eight years.New technologies have resulted in increasing …
- 世界のコンテンツデリバリネットワーク(CDN)市場動向及び予測(2014 – 2019)The market analysis consists of various types of solutions, service providers, organization size, verticals, and regions. The overall market size is calculated by adding up the market size of each solution, such as Content Delivery Network (CDN) delivery, CDN analytics and monitoring, transparent caching and Video Content Management System (VCMS), video indexing, and online video solution. These s …
- Tesoro Corporation：石油・ガスバリューチェーン分析レポート2013Tesoro Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Tesoro Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Tesoro Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
- 組織検査の世界市場：免疫組織化学、in situハイブリダイゼーション、デジタルパソロジー、ワークフロー管理、特殊染色法The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020, at a CAGR of 6.9% from 2015 to 2020. A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the g …
- パワーマネジメントIC（電源IC）の世界市場2016-2020About Global Power Management IC Market The global power management IC market is driven by factors such as increasing demand for energy-efficient devices. A dramatic rise in the consumption and cost of energy worldwide has forced consumers to save energy and devise methods to minimize environmental impacts caused by carbon emissions. This has increased the demand for power-saving electronic produc …
- 精密畜産農業（PLF）の世界市場分析及び予測（2019年-2024年）Precision livestock farming market anticipated growing at CAGR of 9.2% from 2019 to 2024The precision livestock farming market is estimated to be worth USD 3.0 billion in 2019 and is expected to reach USD 4.6 billion by 2024, at a CAGR of 9.2% from 2019 to 2024. The major drivers for the precision livestock farming market are increasing consolidation of livestock farms, increasing herd size of dai …
- 抗凝固薬の世界市場動向：競争状況、パイプライン分析、市場規模予測Summary: DelveInsight Report, “Anticoagulants-Competitive Landscape, Market & Pipeline Analysis, Forecasted Market Size 2015-2018” analyzes that Anticoagulants has lot of future scope and potential in the market. Mostly anticoagulants are being used in Venous Thromboembolism and Atrial Fibrillation. There are 16 anticoagulants in pipeline for venous thromboembolism, Atrial Fibrillation, Acute Coro …
- 高耐熱エラストマーの世界市場：フルオロカーボンエラストマー、フルオロシリコーンエラストマー、パーフルオロカーボンエラストマー等High temperature elastomers are those elastomers which are generally used for applications with high temperature requirements, generally above 150⁰ Celsius. Players in the high temperature elastomers market are investing extensively in development of new and innovative products in order to expand the applicability areas and targent new inndustries. The high temperatuire elastomers market is projec …
